Session

Overview: According to the new ESGO/ESTRO/ESP guidelines, in patients with FIGO stage 2009 IB1 (< 4 cm) cervical cancer with unequivocally pathological pelvic lymphnodes (PLNs) on imaging, definitive radiochemotherapy is recommended to avoid multimodality treatment. In addition, para-aortic lympnode dissection (PALND) may be considered in patients with negative PALNs on imaging to ensure node negative disease. Alternatively, especially in patients with extensive pelvic node disease, elective PAO node irradiation can be applied. Since then, much debate has taken place in the MTBs about how to treat this specific patient group. The value of imaging and surgical staging, and the PROs and CONs of specific treatment options, will be discussed in this joint debate.